Compare AMRX & PDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | PDI |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.1B |
| IPO Year | 2018 | 2012 |
| Metric | AMRX | PDI |
|---|---|---|
| Price | $21.24 | $14.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 2.8M | ★ 3.4M |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.56 | N/A |
| Revenue Next Year | $9.33 | N/A |
| P/E Ratio | $56.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.99 | $13.73 |
| 52 Week High | $21.18 | $19.00 |
| Indicator | AMRX | PDI |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 43.71 |
| Support Level | $16.59 | $13.94 |
| Resistance Level | N/A | $14.56 |
| Average True Range (ATR) | 0.64 | 0.20 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 93.21 | 29.37 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.